Targeting RIP1 and MLKL was shown to suppress MSU-induced cell death in vitro while MLKL-deficient mice lacked tophus formation in a gouty arthritis model, providing further confirmation of the involvement of the RIP1-RIP3-MLKL axis (38). The gene discussed is RIPK1; the disease is gout.